chr2-219210799-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_005689.4(ABCB6):c.2168G>A(p.Arg723Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00109 in 1,613,838 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 2 hom. )
Consequence
ABCB6
NM_005689.4 missense
NM_005689.4 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 6.02
Genes affected
ABCB6 (HGNC:47): (ATP binding cassette subfamily B member 6 (LAN blood group)) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. ABC proteins transport various molecules across extra- and intra-cellular membranes. This protein is a member of the heavy metal importer subfamily and plays a role in porphyrin transport. This gene is the molecular basis of the Langereis (Lan) blood group antigen and mutations in this gene underlie familial pseudohyperkalemia and dyschromatosis universalis hereditaria. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000736 (112/152232) while in subpopulation NFE AF= 0.00134 (91/68022). AF 95% confidence interval is 0.00112. There are 0 homozygotes in gnomad4. There are 52 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 112 AD,BG gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCB6 | NM_005689.4 | c.2168G>A | p.Arg723Gln | missense_variant | 16/19 | ENST00000265316.9 | NP_005680.1 | |
ABCB6 | NM_001349828.2 | c.2030G>A | p.Arg677Gln | missense_variant | 15/18 | NP_001336757.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCB6 | ENST00000265316.9 | c.2168G>A | p.Arg723Gln | missense_variant | 16/19 | 1 | NM_005689.4 | ENSP00000265316.3 | ||
ENSG00000284820 | ENST00000446716.5 | n.*3952G>A | non_coding_transcript_exon_variant | 19/22 | 2 | ENSP00000398528.1 | ||||
ENSG00000284820 | ENST00000446716.5 | n.*3952G>A | 3_prime_UTR_variant | 19/22 | 2 | ENSP00000398528.1 |
Frequencies
GnomAD3 genomes AF: 0.000736 AC: 112AN: 152114Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
112
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000766 AC: 191AN: 249416Hom.: 1 AF XY: 0.000859 AC XY: 116AN XY: 135102
GnomAD3 exomes
AF:
AC:
191
AN:
249416
Hom.:
AF XY:
AC XY:
116
AN XY:
135102
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00113 AC: 1646AN: 1461606Hom.: 2 Cov.: 32 AF XY: 0.00114 AC XY: 826AN XY: 727084
GnomAD4 exome
AF:
AC:
1646
AN:
1461606
Hom.:
Cov.:
32
AF XY:
AC XY:
826
AN XY:
727084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000736 AC: 112AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000699 AC XY: 52AN XY: 74420
GnomAD4 genome
AF:
AC:
112
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
52
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
8
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
9
ExAC
AF:
AC:
101
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 23, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2023 | An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 218181). This missense change has been observed in individual(s) with familial pseudohyperkalemia (PMID: 24947683, 27151991). This variant is present in population databases (rs148211042, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 723 of the ABCB6 protein (p.Arg723Gln). Experimental studies have shown that this missense change affects ABCB6 function (PMID: 27151991). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Familial pseudohyperkalemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2014 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
ABCB6-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 07, 2024 | The ABCB6 c.2168G>A variant is predicted to result in the amino acid substitution p.Arg723Gln. This variant has been reported in multiple unrelated individuals with pseudohyperkalemia and was reported to segregate with disease in four affected individuals in a three generation pedigree (Bawazir et al. 2014. PubMed ID: 24947683; Andolfo et al. 2016. PubMed ID: 27151991). Functional studies found this variant results in increased potassium efflux (Andolfo et al. 2016. PubMed ID: 27151991). This variant is reported in 0.13% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Pathogenic
Sift
Pathogenic
D;.
Sift4G
Pathogenic
D;.
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at